John S. Montalbano bought $95K of ABCL stock

John S. Montalbano, Dir of AbCellera Biologics Inc. (ABCL), bought 20,000 shares of ABCL stock worth $95K, per an SEC Form 4 filed May 18, 2026.

It was an open-market purchase.

The trade happened on May 14, 2026, 4 days before it was made public.

ABCL has moved +164.1% since the trade date, from $4.40 to $11.62 (Nov 12, 2026 close).